{
    "title": "Novo Nordisk, Lilly see insatiable demand for weight-loss drugs",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12703615/Novo-Nordisk-Lilly-insatiable-demand-weight-loss-drugs.html",
    "date": "2023-11-02",
    "keywords": [
        "wegovy",
        "novo",
        "mounjaro",
        "quarter",
        "food",
        "weightloss",
        "obesity",
        "healthcare",
        "demand",
        "year",
        "success",
        "maggie",
        "fick",
        "bhanvi",
        "satija",
        "market",
        "ozempic",
        "thursday",
        "supply",
        "end",
        "company",
        "growth",
        "time",
        "lillys",
        "interview",
        "number",
        "johnson",
        "juggernaut",
        "availability",
        "boom",
        "industry",
        "inability",
        "squeeze",
        "type",
        "offlabel",
        "loss",
        "approval",
        "drugmaker",
        "nordisk",
        "lvmh",
        "record",
        "operating",
        "profit",
        "point",
        "vial",
        "analyst",
        "evan",
        "ingredient",
        "semaglutide",
        "capacity",
        "production",
        "situation",
        "ashkenazi",
        "officer",
        "treatment",
        "cfo",
        "munk",
        "knudsen",
        "publicity",
        "buying",
        "frenzy",
        "pe",
        "question",
        "resume",
        "portfolio",
        "manager",
        "thornburg",
        "investment",
        "management",
        "apnea",
        "packaging",
        "effect",
        "month",
        "surgery",
        "hit",
        "fund",
        "invesco",
        "beverage",
        "etf",
        "retailer",
        "pullback",
        "consumption",
        "reporting",
        "jacob",
        "gronholtpedersen",
        "patrick",
        "wingrove",
        "writing",
        "gaffen",
        "bill",
        "berkrot"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}